Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 82
Summary
- Conditions
- Gastric Cancer
- Gastroesophageal Junction Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 19 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02501603
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sun Young Rha Severance Hospital, Yonsei University Health System, Yonsei Cancer Center
Get Well Soon